高濃度ポリアミンの代謝は,GCN2の活性化によって線維細胞を活性化し,老化した線維細胞を生成し,腫瘍の形成と進行を促進する
Eric T Alexander1, Katherine S Barone1, Susan K Gilmour1
1Lankenau Institute for Medical Research, Wynnewood, Pennsylvania, USA.
Molecular carcinogenesis
|August 20, 2025
まとめ
ポリアミンのバイオシンセシスが増加すると,GCN2のストレス反応が活性化し,線維細胞の活性化が促進され,腫瘍を支える微小環境が形成されます. GCN2または老化ファイブロブラストを阻害すると,皮膚腫瘍の発症を大幅に遅らせます.
科学分野:
- 腫瘍学
- 細胞生物学
- 生物化学
背景:
- タンパク質キナーゼ2 (GCN2) は,アミノ酸飢餓の重要なセンサーです.
- 腫瘍の微小環境は,GCN2を活性化し,腫瘍の生存を助長する重要なストレスをもたらします.
- ポリアミンは細胞の成長と増殖に不可欠であり,その調節不良は癌に関与しています.
研究 の 目的:
- GCN2の活性化とストロマ細胞の代謝の変化における高ポリアミン生物合成の役割を調査する.
- これらの変化が腫瘍細胞の生存と 骨髄性免疫抑制機能をどのようにサポートするかを決定する.
- GCN2活性化フィブロブラストと老化が皮膚がん発生に与える影響を明らかにする.
主な方法:
- ポリアミン誘発性皮膚がんのモデルであるK6/ODC変異性マウスを利用した.
- GCN2欠乏したK6/ODCマウスを生成し,分析した (K6/ODC; GCN2-/-).
- 皮膚線維細胞の活性化,老化,および原発性の因子の分泌を調査した.
- K6/ODC;p16-3MRマウスを使用して老化した線維芽細胞を排除した.
主要な成果:
- GCN2欠乏症は,腫瘍の発達を著しく遅らせ,腫瘍の数を減少させ,腫瘍の負荷を減少させた.
- K6/ODCマウスの皮膚線維芽細胞は,GCN2活性化と線維芽細胞活性化マーカーの上昇を示した.
- K6 / ODCマウスは,GCN2欠乏症で減少した,骨髄由来抑制細胞 (MDSC) の増加を示した.
- K6/ODCの老化ファイブロブラストの除去;p16- 3MRマウスは腫瘍の発達を大幅に抑制した.
結論:
- ポリアミンのバイオシンセシスの増加はGCN2の活性化を引き起こし,繊維細胞の活性化と老化につながる.
- このGCN2媒介のストロマの再プログラミングは,腫瘍の成長と免疫抑制をサポートする原発的微環境を作り出します.
- GCN2または老化した線維芽細胞を標的とした治療は,皮膚がんに対する潜在的な治療戦略です.
関連する概念動画
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Cancer-Critical Genes I: Proto-oncogenes
9.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K


